<p>根据 Carmel Capital Partners LLC 在最近向证券交易委员会提交的文件，该公司在第二季度将其在安捷伦科技公司（NYSE:A - 免费报告）的持股增加了 32.3%。该公司在此期间额外购买了 2,667 股后，持有 10,928 股该医疗研究公司的股票。根据其最近的 SEC 文件，Carmel Capital Partners LLC 在安捷伦科技的持股价值为 1,290,000 美元。</p>
<p>获取 <strong>安捷伦科技</strong> 的提醒：</p>
<ul>
<li>MarketBeat 周报 – 10/13 - 10/17</li>
</ul>
<p>其他一些对冲基金也对其在 A 的持仓进行了调整。Generation Investment Management LLP 在第一季度将其在安捷伦科技的股份增加了 19.8%。Generation Investment Management LLP 目前持有 4,983,556 股该医疗研究公司的股票，价值 582,976,000 美元，此前在此期间额外购买了 824,243 股。瑞银资产管理的一个独立业务单位在第一季度将其在安捷伦科技的股份增加了 18.7%。瑞银资产管理的该独立业务单位目前持有 3,836,105 股该医疗研究公司的股票，价值 448,748,000 美元，此前在此期间额外购买了 604,124 股。Mackenzie Financial Corp 在第一季度将其在安捷伦科技的股份增加了 141.5%。Mackenzie Financial Corp 目前持有 935,893 股该医疗研究公司的股票，价值 109,481,000 美元，此前在此期间额外购买了 548,344 股。Woodline Partners LP 在第一季度将其在安捷伦科技的股份增加了 681.6%。Woodline Partners LP 目前持有 522,073 股该医疗研究公司的股票，价值 61,072,000 美元，此前在此期间额外购买了 455,276 股。最后，Nordea Investment Management AB 在第二季度将其在安捷伦科技的股份增加了 16.2%。Nordea Investment Management AB 目前持有 3,213,748 股该医疗研究公司的股票，价值 383,143,000 美元，此前在此期间额外购买了 447,207 股。</p>
<h2>安捷伦科技价格表现</h2>
<p>周五，A 的开盘价为 142.01 美元。该公司的 50 日移动平均线为 127.58 美元，200 日移动平均线为 117.83 美元。该公司的市值为 402.6 亿美元，市盈率为 33.34，市盈增长比率为 4.61，贝塔系数为 1.26。安捷伦科技的 1 年最低价为 96.43 美元，1 年最高价为 153.84 美元。该公司的债务与股本比率为 0.53，速动比率为 1.71，流动比率为 2.25。</p>
<ul>
<li>雅培实验室的十月价格暴跌是买入信号</li>
</ul>
<p>安捷伦科技（NYSE:A - 获取免费报告）最近于 8 月 27 日发布了其财报。该医疗研究公司报告季度每股收益为 1.37 美元，符合市场共识预期的 1.37 美元。该公司在本季度的收入为 17.4 亿美元，而市场共识预期为 16.7 亿美元。安捷伦科技的净利润率为 17.97%，股本回报率为 25.51%。该公司的收入同比增长 10.1%。在去年同期，该公司每股收益为 1.32 美元。安捷伦科技已将其 2025 财年的指导目标设定为 5.560-5.590 美元每股。2025 财年第 4 季度的指导目标为 1.570-1.600 美元每股。股票分析师预计安捷伦科技将在当前财年发布 5.58 美元每股的业绩。</p>
<h2>安捷伦科技股息公告</h2>
<p>该公司最近还披露了一项季度股息，将于 10 月 22 日（星期三）支付。9 月 30 日（星期二）登记的投资者将获得每股 0.248 美元的股息。这相当于年化股息 0.99 美元，股息收益率为 0.7%。该股息的除息日期为 9 月 30 日（星期二）。安捷伦科技的股息支付比率目前为 23.24%。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>Archer 收购竞争对手的专利宝藏，进行战略性举措</li>
</ul>
<p>A 一直是几份分析师报告的主题。Rothschild &amp; Co Redburn 在 10 月 8 日（星期三）的一份研究报告中对安捷伦科技的股票进行了覆盖，给予 “买入” 评级，目标价为 165.00 美元。Weiss Ratings 在 10 月 8 日（星期三）的一份研究报告中重申了对安捷伦科技的 “持有（c）” 评级。巴克莱在 10 月 2 日（星期四）将安捷伦科技的目标价从 125.00 美元上调至 150.00 美元，并给予该股票 “等权重” 评级。瑞银集团在 10 月 8 日（星期三）将安捷伦科技的评级从 “中性” 上调至 “买入”，并将其目标价从 130.00 美元上调至 170.00 美元。最后，TD Cowen 在周二将安捷伦科技的目标价从 150.00 美元上调至 162.00 美元，并给予该股票 “买入” 评级。一位股票研究分析师对该股票给予了强烈买入评级，八位给予了买入评级，六位对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 149.62 美元。</p>
<p><strong>查看我们最新的 A 研究报告</strong></p>
<h2>安捷伦科技简介</h2>
<p>（免费报告）</p>
<p>安捷伦科技公司为全球生命科学、诊断和应用化学市场提供应用导向的解决方案。该公司分为三个部门：生命科学与应用市场、诊断与基因组学，以及安捷伦跨实验室。生命科学与应用市场部门提供液相色谱系统及其组件；液相色谱质谱系统；气相色谱系统及其组件；气相色谱质谱系统；感应耦合等离子体质谱仪；原子吸收仪器；微波等离子体 - 原子发射光谱仪；感应耦合等离子体光学发射光谱仪；拉曼光谱；细胞分析板基于的检测；流式细胞仪；实时细胞分析仪；细胞成像系统；微孔板读数仪；实验室软件；信息管理与分析；实验室自动化与机器人系统；溶出测试；真空泵和测量技术。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比安捷伦科技更好</li>
<li>什么是财报？</li>
<li>这家人工智能芯片巨头可能是市场下一个大赢家</li>
<li>低市盈率成长股：解锁投资机会</li>
<li>博通与 OpenAI 达成协议：为何这对 AVGO 股票是一个巨大的胜利</li>
<li>比较和交易高市盈率股票</li>
<li>机构正在推动 CrowdStrike 的下一轮上涨</li>
</ul>
<p><strong>想看看其他对 A 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取安捷伦科技公司（NYSE:A - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在安捷伦科技吗？</h2>
<p>在你考虑安捷伦科技之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而安捷伦科技并不在名单上。</p>
<p>虽然安捷伦科技目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

安捷伦科技

<p>Carmel Capital Partners LLC 在第二季度将其在安捷伦科技公司（Agilent Technologies, Inc.）的持股增加了 32.3%，目前持有 10,928 股，价值 129 万美元。其他对冲基金也提高了他们的持仓。安捷伦的股票开盘价为 142.01 美元，市值为 402.6 亿美元。该公司报告第三季度每股收益为 1.37 美元，符合预期，营收为 17.4 亿美元。每股 0.248 美元的季度股息将于 10 月 22 日支付。分析师设定的目标价格范围为 150 美元至 170 美元，评级从 “买入” 到 “持有” 不等</p>

<p>Carmel Capital Partners LLC grew its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 32.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,928 shares of the medical research company's stock after acquiring an additional 2,667 shares during the period. Carmel Capital Partners LLC's holdings in Agilent Technologies were worth $1,290,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根据 Carmel Capital Partners LLC 在最近向证券交易委员会提交的文件，该公司在第二季度将其在安捷伦科技公司（NYSE:A - 免费报告）的持股增加了 32.3%。该公司在此期间额外购买了 2,667 股后，持有 10,928 股该医疗研究公司的股票。根据其最近的 SEC 文件，Carmel Capital Partners LLC 在安捷伦科技的持股价值为 1,290,000 美元。</p>
</div><p>Get <strong>Agilent Technologies</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>安捷伦科技</strong> 的提醒：</p>
</div><ul>
<li>MarketBeat Week in Review – 10/13 - 10/17</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 10/13 - 10/17</li>
</ul>
</div><p>A number of other hedge funds have also made changes to their positions in A. Generation Investment Management LLP raised its stake in shares of Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after acquiring an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock worth $448,748,000 after buying an additional 604,124 shares during the period. Mackenzie Financial Corp increased its stake in Agilent Technologies by 141.5% during the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock worth $109,481,000 after buying an additional 548,344 shares during the period. Woodline Partners LP increased its stake in Agilent Technologies by 681.6% during the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company's stock worth $61,072,000 after buying an additional 455,276 shares during the period. Finally, Nordea Investment Management AB increased its stake in Agilent Technologies by 16.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company's stock worth $383,143,000 after buying an additional 447,207 shares during the period.</p>
<div class="lb-trans"><p>其他一些对冲基金也对其在 A 的持仓进行了调整。Generation Investment Management LLP 在第一季度将其在安捷伦科技的股份增加了 19.8%。Generation Investment Management LLP 目前持有 4,983,556 股该医疗研究公司的股票，价值 582,976,000 美元，此前在此期间额外购买了 824,243 股。瑞银资产管理的一个独立业务单位在第一季度将其在安捷伦科技的股份增加了 18.7%。瑞银资产管理的该独立业务单位目前持有 3,836,105 股该医疗研究公司的股票，价值 448,748,000 美元，此前在此期间额外购买了 604,124 股。Mackenzie Financial Corp 在第一季度将其在安捷伦科技的股份增加了 141.5%。Mackenzie Financial Corp 目前持有 935,893 股该医疗研究公司的股票，价值 109,481,000 美元，此前在此期间额外购买了 548,344 股。Woodline Partners LP 在第一季度将其在安捷伦科技的股份增加了 681.6%。Woodline Partners LP 目前持有 522,073 股该医疗研究公司的股票，价值 61,072,000 美元，此前在此期间额外购买了 455,276 股。最后，Nordea Investment Management AB 在第二季度将其在安捷伦科技的股份增加了 16.2%。Nordea Investment Management AB 目前持有 3,213,748 股该医疗研究公司的股票，价值 383,143,000 美元，此前在此期间额外购买了 447,207 股。</p>
</div><h2>Agilent Technologies Price Performance</h2>
<div class="lb-trans"><h2>安捷伦科技价格表现</h2>
</div><p>A opened at $142.01 on Friday. The company has a 50-day moving average of $127.58 and a 200-day moving average of $117.83. The company has a market capitalization of $40.26 billion, a P/E ratio of 33.34, a PEG ratio of 4.61 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.</p>
<div class="lb-trans"><p>周五，A 的开盘价为 142.01 美元。该公司的 50 日移动平均线为 127.58 美元，200 日移动平均线为 117.83 美元。该公司的市值为 402.6 亿美元，市盈率为 33.34，市盈增长比率为 4.61，贝塔系数为 1.26。安捷伦科技的 1 年最低价为 96.43 美元，1 年最高价为 153.84 美元。该公司的债务与股本比率为 0.53，速动比率为 1.71，流动比率为 2.25。</p>
</div><ul>
<li>Abbott Laboratories' October Price Plunge Is a Signal to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>雅培实验室的十月价格暴跌是买入信号</li>
</ul>
</div><p>Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>安捷伦科技（NYSE:A - 获取免费报告）最近于 8 月 27 日发布了其财报。该医疗研究公司报告季度每股收益为 1.37 美元，符合市场共识预期的 1.37 美元。该公司在本季度的收入为 17.4 亿美元，而市场共识预期为 16.7 亿美元。安捷伦科技的净利润率为 17.97%，股本回报率为 25.51%。该公司的收入同比增长 10.1%。在去年同期，该公司每股收益为 1.32 美元。安捷伦科技已将其 2025 财年的指导目标设定为 5.560-5.590 美元每股。2025 财年第 4 季度的指导目标为 1.570-1.600 美元每股。股票分析师预计安捷伦科技将在当前财年发布 5.58 美元每股的业绩。</p>
</div><h2>Agilent Technologies Dividend Announcement</h2>
<div class="lb-trans"><h2>安捷伦科技股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's dividend payout ratio is currently 23.24%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度股息，将于 10 月 22 日（星期三）支付。9 月 30 日（星期二）登记的投资者将获得每股 0.248 美元的股息。这相当于年化股息 0.99 美元，股息收益率为 0.7%。该股息的除息日期为 9 月 30 日（星期二）。安捷伦科技的股息支付比率目前为 23.24%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>Archer Buys Rival's Patent Treasure Trove in Strategic Move</li>
</ul>
<div class="lb-trans"><ul>
<li>Archer 收购竞争对手的专利宝藏，进行战略性举措</li>
</ul>
</div><p>A has been the topic of several analyst reports. Rothschild &amp; Co Redburn initiated coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They set a &#34;buy&#34; rating and a $165.00 price target on the stock. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Thursday, October 2nd. UBS Group raised shares of Agilent Technologies from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and lifted their price target for the stock from $130.00 to $170.00 in a research note on Wednesday, October 8th. Finally, TD Cowen lifted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a &#34;buy&#34; rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $149.62.</p>
<div class="lb-trans"><p>A 一直是几份分析师报告的主题。Rothschild &amp; Co Redburn 在 10 月 8 日（星期三）的一份研究报告中对安捷伦科技的股票进行了覆盖，给予 “买入” 评级，目标价为 165.00 美元。Weiss Ratings 在 10 月 8 日（星期三）的一份研究报告中重申了对安捷伦科技的 “持有（c）” 评级。巴克莱在 10 月 2 日（星期四）将安捷伦科技的目标价从 125.00 美元上调至 150.00 美元，并给予该股票 “等权重” 评级。瑞银集团在 10 月 8 日（星期三）将安捷伦科技的评级从 “中性” 上调至 “买入”，并将其目标价从 130.00 美元上调至 170.00 美元。最后，TD Cowen 在周二将安捷伦科技的目标价从 150.00 美元上调至 162.00 美元，并给予该股票 “买入” 评级。一位股票研究分析师对该股票给予了强烈买入评级，八位给予了买入评级，六位对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 149.62 美元。</p>
</div><p><strong>View Our Latest Research Report on A</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 A 研究报告</strong></p>
</div><h2>Agilent Technologies Profile</h2>
<div class="lb-trans"><h2>安捷伦科技简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.</p>
<div class="lb-trans"><p>安捷伦科技公司为全球生命科学、诊断和应用化学市场提供应用导向的解决方案。该公司分为三个部门：生命科学与应用市场、诊断与基因组学，以及安捷伦跨实验室。生命科学与应用市场部门提供液相色谱系统及其组件；液相色谱质谱系统；气相色谱系统及其组件；气相色谱质谱系统；感应耦合等离子体质谱仪；原子吸收仪器；微波等离子体 - 原子发射光谱仪；感应耦合等离子体光学发射光谱仪；拉曼光谱；细胞分析板基于的检测；流式细胞仪；实时细胞分析仪；细胞成像系统；微孔板读数仪；实验室软件；信息管理与分析；实验室自动化与机器人系统；溶出测试；真空泵和测量技术。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Agilent Technologies</li>
<li>What Are Earnings Reports?</li>
<li>This AI Chip Giant Could Be the Market’s Next Big Winner</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock</li>
<li>Comparing and Trading High PE Ratio Stocks</li>
<li>Institutions Are Fueling CrowdStrike’s Next Leg Higher</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比安捷伦科技更好</li>
<li>什么是财报？</li>
<li>这家人工智能芯片巨头可能是市场下一个大赢家</li>
<li>低市盈率成长股：解锁投资机会</li>
<li>博通与 OpenAI 达成协议：为何这对 AVGO 股票是一个巨大的胜利</li>
<li>比较和交易高市盈率股票</li>
<li>机构正在推动 CrowdStrike 的下一轮上涨</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding A?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 A 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取安捷伦科技公司（NYSE:A - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=A"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Agilent Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在安捷伦科技吗？</h2>
</div><p>Before you consider Agilent Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑安捷伦科技之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而安捷伦科技并不在名单上。</p>
</div><p>While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然安捷伦科技目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Carmel Capital Partners LLC 增加了其在安捷伦科技公司的股票持仓